[Federal Register Volume 64, Number 168 (Tuesday, August 31, 1999)]
[Notices]
[Page 47510]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-22559]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the National Advisory Council on Drug Abuse.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council on Drug Abuse.
Date: September 14-15, 1999.
Closed: September 14, 1999, 1 PM to adjournment.
Agenda: To review and evaluate grant applications.
Place: Neuroscience Center, National Institutes of Health, 6001
Executive Blvd., Bethesda, MD 20892.
Open: September 15, 1999, 9 AM to adjournment.
Agenda: This portion of the meeting will be open to the public
for announcements and reports of administrative, legislative and
program developments in the drug abuse field.
Place: Neuroscience Center, National Institutes of Health, 6001
Executive Blvd., Bethesda, MD 20892.
Contact Person: Teresa Levitin, PhD; Director, Office of
Extramural Program Review, National Institutes on Drug Abuse,
National Institute of Health, DHHS, Bethesda, MD 20892-9547; (301)
443-2755.
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse Research Programs, National Institutes of Health,
HHS)
Dated: August 24, 1999.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy, NIH.
[FR Doc. 99-22559 Filed 8-30-99; 8:45 am]
BILLING CODE 4140-01-M
